Palisade Bio, Inc.
PALI
$0.6902
-$0.0638-8.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.85M | -13.14M | -14.44M | -14.07M | -14.17M |
| Total Depreciation and Amortization | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 499.00K | 800.00K | 851.00K | 832.00K | 1.26M |
| Change in Net Operating Assets | 1.68M | 992.00K | 1.39M | 672.00K | 823.00K |
| Cash from Operations | -9.66M | -11.35M | -12.19M | -12.56M | -12.09M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -348.00K | -348.00K | -426.00K | -371.00K | -411.00K |
| Issuance of Common Stock | 4.44M | 8.45M | 10.95M | 6.53M | 8.27M |
| Repurchase of Common Stock | 0.00 | -25.00K | -25.00K | -25.00K | -25.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -366.00K | -776.00K | -919.00K | -849.00K | -796.00K |
| Cash from Financing | 3.73M | 7.30M | 9.58M | 5.29M | 7.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.94M | -4.05M | -2.61M | -7.27M | -5.05M |